These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29023266)

  • 1. Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease.
    Conrad MA; Dawany N; Sullivan KE; Devoto M; Kelsen JR
    Inflamm Bowel Dis; 2017 Dec; 23(12):2252-2255. PubMed ID: 29023266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    de Greef JC; Wang J; Balog J; den Dunnen JT; Frants RR; Straasheijm KR; Aytekin C; van der Burg M; Duprez L; Ferster A; Gennery AR; Gimelli G; Reisli I; Schuetz C; Schulz A; Smeets DFCM; Sznajer Y; Wijmenga C; van Eggermond MC; van Ostaijen-Ten Dam MM; Lankester AC; van Tol MJD; van den Elsen PJ; Weemaes CM; van der Maarel SM
    Am J Hum Genet; 2011 Jun; 88(6):796-804. PubMed ID: 21596365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
    van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
    Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined immunodeficiency develops with age in Immunodeficiency-centromeric instability-facial anomalies syndrome 2 (ICF2).
    von Bernuth H; Ravindran E; Du H; Fröhler S; Strehl K; Krämer N; Issa-Jahns L; Amulic B; Ninnemann O; Xiao MS; Eirich K; Kölsch U; Hauptmann K; John R; Schindler D; Wahn V; Chen W; Kaindl AM
    Orphanet J Rare Dis; 2014 Oct; 9():116. PubMed ID: 25330735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Types of Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome Identified by Whole-Exome Sequencing in Saudi Hypogammaglobulinemia Patients: Clinical, Molecular, and Cytogenetic Features.
    Alghamdi HA; Tashkandi SA; Alidrissi EM; Aledielah RD; AlSaidi KA; Alharbi ES; Habazi MK; Alzahrani MS
    J Clin Immunol; 2018 Nov; 38(8):847-853. PubMed ID: 30511102
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and Immunological Characterization of ICF Syndrome in Japan.
    Kamae C; Imai K; Kato T; Okano T; Honma K; Nakagawa N; Yeh TW; Noguchi E; Ohara A; Shigemura T; Takahashi H; Takakura S; Hayashi M; Honma A; Watanabe S; Shigemori T; Ohara O; Sasaki H; Kubota T; Morio T; Kanegane H; Nonoyama S
    J Clin Immunol; 2018 Nov; 38(8):927-937. PubMed ID: 30353301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients.
    Nitta H; Unoki M; Ichiyanagi K; Kosho T; Shigemura T; Takahashi H; Velasco G; Francastel C; Picard C; Kubota T; Sasaki H
    J Hum Genet; 2013 Jul; 58(7):455-60. PubMed ID: 23739126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and genetic manifestations of immunodeficiency, centromeric instability, and facial anomalies syndrome: a case report and literature review].
    Hu SC; Wang YB; Sun Q; Liu XR; Sun LL; Cui GM
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):55-59. PubMed ID: 30630233
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    Chouery E; Abou-Ghoch J; Corbani S; El Ali N; Korban R; Salem N; Castro C; Klayme S; Azoury-Abou Rjeily M; Khoury-Matar R; Debo G; Germanos-Haddad M; Delague V; Lefranc G; Mégarbané A
    Clin Genet; 2012 Nov; 82(5):489-93. PubMed ID: 21906047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel iPSC-based model of ICF syndrome subtype 2 recapitulates the molecular phenotype of ZBTB24 deficiency.
    Lullo V; Cecere F; Batti S; Allegretti S; Morone B; Fioriniello S; Pisapia L; Genesio R; Della Ragione F; Giardino G; Pignata C; Riccio A; Matarazzo MR; Strazzullo M
    Front Immunol; 2024; 15():1419748. PubMed ID: 39040103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome.
    Hu H; Chen C; Shi S; Li B; Duan S
    Autoimmunity; 2019; 52(5-6):192-198. PubMed ID: 31476899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel
    Aminorroaya A; Rayzan E; Shahkarami S; Seyedpour S; Zoghi S; Aryan Z; Somekh I; Rohlfs M; Klein C; Esmaeilzadeh H; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):410-415. PubMed ID: 35996251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.
    Kelsen JR; Dawany N; Moran CJ; Petersen BS; Sarmady M; Sasson A; Pauly-Hubbard H; Martinez A; Maurer K; Soong J; Rappaport E; Franke A; Keller A; Winter HS; Mamula P; Piccoli D; Artis D; Sonnenberg GF; Daly M; Sullivan KE; Baldassano RN; Devoto M
    Gastroenterology; 2015 Nov; 149(6):1415-24. PubMed ID: 26193622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome, due to ZBTB24 mutations, presenting with large cerebral cyst.
    Cerbone M; Wang J; Van der Maarel SM; D'Amico A; D'Agostino A; Romano A; Brunetti-Pierri N
    Am J Med Genet A; 2012 Aug; 158A(8):2043-6. PubMed ID: 22786748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.
    Weemaes CM; van Tol MJ; Wang J; van Ostaijen-ten Dam MM; van Eggermond MC; Thijssen PE; Aytekin C; Brunetti-Pierri N; van der Burg M; Graham Davies E; Ferster A; Furthner D; Gimelli G; Gennery A; Kloeckener-Gruissem B; Meyn S; Powell C; Reisli I; Schuetz C; Schulz A; Shugar A; van den Elsen PJ; van der Maarel SM
    Eur J Hum Genet; 2013 Nov; 21(11):1219-25. PubMed ID: 23486536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodeficiency, Centromeric Region Instability, and Facial Anomalies Syndrome (ICF) in a Boy with Variable Clinical and Immunological Presentations.
    Bemanian MH; Arshi S; Nabavi M; Vafaee-Shahi M; Fallahpour M; Shokri S; Rezaeifar A; Shahzadi H; Atashrazm F
    Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):249-254. PubMed ID: 33904683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
    Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
    J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals.
    Wu H; Thijssen PE; de Klerk E; Vonk KK; Wang J; den Hamer B; Aytekin C; van der Maarel SM; Daxinger L
    Hum Mol Genet; 2016 Sep; 25(18):4041-4051. PubMed ID: 27466202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Immunologic and Molecular Spectrum of Patients with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review.
    Kiaee F; Zaki-Dizaji M; Hafezi N; Almasi-Hashiani A; Hamedifar H; Sabzevari A; Shirkani A; Zian Z; Jadidi-Niaragh F; Aghamahdi F; Goudarzvand M; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
    Endocr Metab Immune Disord Drug Targets; 2021; 21(4):664-672. PubMed ID: 32533820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.